X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Elder Pharma Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Elder Pharma Quarterly Results   (ELDER)

Here are the latest quarterly results of Elder Pharma. For more details, see the Elder Pharma financial fact sheet and Elder Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Elder Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-13
*
3
Sep-13
*
3
Dec-13
*
3
Mar-14
*
3
Jun-14
*
3
Sep-14
*
3
Dec-14
*
3
Mar-15
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,8512,7283,8712,2891,2022,0311,5791,521 
Other income Rs m2364441272193911 
Turnover Rs m1,8742,7923,9142,4161,2232,1251,5891,531 
Expenses Rs m1,2752,2883,5362,3742,6842,2871,8851,637 
Gross profit Rs m575440335-85-1,482-256-305-116 
Depreciation Rs m8292111956311389104 
Interest Rs m4783684936951,200232450225 
Profit before tax Rs m3844-225-748-2,724-508-836-434 
Tax Rs m01331701029 
Profit after tax Rs m3831-229-765-2,723-509-836-463 
Gross profit margin %31.116.18.7-3.7-123.2-12.6-19.3-7.6 
Effective tax rate %-0.728.6-1.4-2.30.0-0.30.0-6.6 
Net profit margin %2.11.2-5.9-33.4-226.5-25.1-52.9-30.4 
Diluted EPS Rs 1.9 1.5 -11.1 -37.3 -132.6 -24.8 -40.7 -22.5  
Diluted EPS (TTM) Rs 31.4 20.1 -0.1 -45.0 -179.4 -205.7 -235.3 -220.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   PFIZER  NATCO PHARMA  FRESENIUS KABI ONCO.  STRIDES SHASUN LTD  MERCK LTD  

Compare ELDER PHARMA With:   PFIZER  NATCO PHARMA  FRESENIUS KABI ONCO.  STRIDES SHASUN LTD  MERCK LTD  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend; Realty Stocks Top Losers(01:30 pm)

After opening the day lower, share markets in India have continued the downtrend and are currently trading below the dotted line. Sectoral indices are trading on a negative note with stocks.

Views on news

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Rule-Based Investing Can Make A Lot of Money(The 5 Minute Wrapup)

Sep 16, 2017

We take a glimpse of Equitymaster's results from rule based investing.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Gold Imports Surge: Are People Hedging the Risk of Another Demonetisation?(Vivek Kaul's Diary)

Sep 19, 2017

Imports of the yellow metal have surged big time this year.

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

A Little-Known Japanese Secret for Compounding Wealth

Sep 22, 2017

What Warren Buffett and Benjamin Graham have in common with a little known Japanese secret.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ELDER PHARMA

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS